Medicare Enrolled

Dr. Jerald Sklar, M. D.

Dermatology · Dallas, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
10703 PRESTON RD, Dallas, TX 75230
2149873376
In practice since 2005 (20 years)
NPI: 1821086679 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Sklar from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sklar? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Sklar

Dr. Jerald Sklar is a dermatology specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sklar performed 13,944 Medicare services across 6,283 unique beneficiaries.

Between the years covered by Open Payments, Dr. Sklar received a total of $37,893 from 54 pharmaceutical and/or device companies across 1236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Sklar is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 4% volume in TX $37,893 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,944
Medicare services
Top 4% in TX for dermatology
6,283
Unique beneficiaries
$32
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~697 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Destruction of precancerous skin growths, 2-14 6,323 $5 $14
Office visit, established patient (20-29 min) 2,557 $60 $186
Destruction of precancerous skin growth, 1 1,945 $38 $136
Steroid injection (triamcinolone) 755 $1 $18
Destruction of skin growths (warts/lesions), 1-14 686 $74 $236
New patient office visit (30-44 min) 254 $73 $228
Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm 172 $77 $259
Skin biopsy, tangential 140 $59 $217
Drug injection, under skin or into muscle 127 $10 $29
Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm 115 $120 $307
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm 101 $93 $290
Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm 86 $100 $295
Office visit, established patient (10-19 min) 83 $40 $115
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm 80 $152 $425
Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm 78 $133 $390
Destruction of precancer skin growth, 15 or more growths 67 $129 $343
Office visit, established patient (30-39 min) 60 $83 $253
Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm 58 $128 $371
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm 47 $74 $260
Biopsy of related skin growth, each additional growth 35 $41 $110
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm 34 $114 $332
Shaving of skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm 31 $101 $301
Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less 27 $72 $247
Destruction of cancer skin growth of trunk, arms, or legs, 2.1-3.0 cm 23 $138 $399
Injection into skin growth, 1-7 growths 21 $31 $116
Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm 21 $81 $307
Shaving of skin growth of body, arms, or legs, 0.5 cm or less 18 $60 $215
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$37,893
Total received (2018-2024)
Avg $5,413/year across 7 years
Top 9% in TX for dermatology
54
Companies
1,236
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$25,428 (67.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$10,254 (27.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,211 (5.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,320
2023
$4,782
2022
$4,304
2021
$3,007
2020
$2,677
2019
$12,918
2018
$5,885

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Almirall LLC
$11,335
Ortho Dermatologics, a division of Bausch Health US, LLC
$3,517
GENZYME CORPORATION
$2,226
Regeneron Healthcare Solutions, Inc.
$2,003
Novartis Pharmaceuticals Corporation
$1,971
Galderma Laboratories, L.P.
$1,664
Dermavant Sciences, Inc.
$1,560
AbbVie Inc.
$1,288
ABBVIE INC.
$1,264
Lilly USA, LLC
$1,175
Amgen Inc.
$1,061
Janssen Biotech, Inc.
$1,026
LEO Pharma Inc.
$967
AbbVie, Inc.
$793
PFIZER INC.
$660
Encore Dermatology Inc.
$621
Sun Pharmaceutical Industries Inc.
$599
Arcutis Biotherapeutics, Inc.
$578
Incyte Corporation
$532
Mayne Pharma Inc.
$397
SUN PHARMACEUTICAL INDUSTRIES INC.
$327
E.R. Squibb & Sons, L.L.C.
$212
Celgene Corporation
$194
Merz North America, Inc.
$189
UCB, Inc.
$186
Kerecis Limited
$176
MAYNE PHARMA INC.
$173
Boehringer Ingelheim Pharmaceuticals, Inc.
$158
EPI Health, LLC
$114
Nabriva Therapeutics, plc
$89
Medimetriks Pharmaceuticals, Inc.
$64
MAYNE PHARMA COMMERCIAL LLC
$59
DERMIRA, INC.
$57
REVANCE THERAPEUTICS, INC.
$56
Novum Pharma, LLC
$50
Journey Medical Corporation
$49
Allergan Inc.
$48
Allergan, Inc.
$46
Verrica Pharmaceuticals Inc.
$46
Janssen Scientific Affairs, LLC
$44
Genentech USA, Inc.
$43
Promius Pharma LLC
$36
VYNE Pharmaceuticals Inc.
$35
SANOFI-AVENTIS U.S. LLC
$32
Tactile Systems Technology Inc
$32
Biofrontera Inc.
$22
Aclaris Therapeutics, Inc.
$20
Bayer HealthCare Pharmaceuticals Inc.
$18
Taro Pharmaceuticals USA, Inc.
$17
Mylan Pharmaceuticals Inc.
$15
Paratek Pharmaceuticals, Inc.
$14
Kowa Pharmaceuticals America, Inc.
$13
Johnson & Johnson Vision Care, Inc.
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 45.1% of total payments
Associated products mentioned in payments ›
ABSORICA · ABSORICA (isotretinoin) · ABSORICA LD · ADBRY · AKLIEF · ALTRENO · AMELUZ · AMZEEQ · ARAZLO · Absorica LD · Acticlate · Aczone · Alcortin A · BLU-U · BOTOX · Bensal HP · Bimzelx · CLODERM · COSENTYX · Cabtreo · Cimzia · Clindamycin Phosphate and Benzoyl Peroxide · Cordran · Cordran Tape · DALVANCE · DAXXIFY · DORYX · DUOBRII · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · ENSTILAR · EPIDUO FORTE · EPSOLAY · ESKATA · EUCRISA · Enbrel · FINACEA · Finacea · Flexitouch Plus · Genadur · HALOG OINTMENT (Halcinonide Ointment · HUMIRA · Humira · ILUMYA · ILUMYA (tildrakizumab-asmn) injection · Ilumya · Impoyz · JUBLIA · Kerecis Omega3 SurgiClose · Ketodan · Klisyri · LIBTAYO · LITFULO · Livalo · NUZYRA · Neo-Synalar · ONEXTON · OPZELURA · ORACEA · Otezla · QBREXZA · REMICADE · RINVOQ · Rituxan · SEYSARA · SILIQ · SIVEXTRO · SKYRIZI · SOOLANTRA · SPEVIGO · Sernivo · Seysara · Sivextro · Skyrizi · Sotyktu · TALTZ · TREMFYA · TWYNEO · Tremfya · Trianex · USP) 0.1% · VTAMA · Veltin · WYNZORA · Winlevi · XOLAIR · Xolair · YCANTH · Zoryve
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (67%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for dermatology in TX.

Equivalent to $272 per 100 Medicare services performed
Looking for a dermatology specialist in Dallas?
Compare dermatologists in the Dallas area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
222
Per 100K population
8.5
County median income
$74,149
Nearest hospital
MEDICAL CITY DALLAS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Sklar is a clinical cardiology specialist, with above-average Medicare volume (top 4% in TX), with low-engagement industry engagement in the top 9% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Sklar experienced with destruction of precancerous skin growths, 2-14?
Based on Medicare claims data, Dr. Sklar performed 6,323 destruction of precancerous skin growths, 2-14 services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Sklar receive payments from pharmaceutical companies?
Yes. Dr. Sklar received a total of $37,893 from 54 companies across 1,236 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sklar's costs compare to other dermatologists in Dallas?
Dr. Sklar's average Medicare payment per service is $32. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sklar) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →